
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
[ Wed, May 22nd 2024 ]: WOPRAI
Robert Burns Reiterated (ATRA) at Hold on, May 22nd, 2024


🞛 This publication is a summary or evaluation of another publication
Robert Burns of HC Wainwright & Co., Reiterated "Atara Biotherapeutics, Inc." (ATRA) at Hold on, May 22nd, 2024.
Robert has made no other calls on ATRA in the last 4 months.
There is 1 other peer that has a rating on ATRA. Out of the 1 peers that are also analyzing ATRA, all agrees with Robert's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Benjamin Burnett of "Stifel" Maintained at Hold with Decreased Target to $58 on, Monday, April 1st, 2024